Analysis for CPAY

$406.20 +13.18 (+3.35%)

📈 Growth — 16/30
💰 Profitability — 18/20
🏦 Financial Health — 14/20
💵 Valuation — 14/20
⚠️ Risk — 6/10

Overall Score: 66/100

Summary:

📈 Growth & Financial Trajectory

Across 8 quarters, revenues rose from about $1.00B in 2025 Q1 to $1.34B in 2026 Q2, a ~33% increase. Net income attributable to parent hovered around $248–284M, finishing near $248M in 2026 Q2, indicating solid profitability but a near-term plateau. The trend shows scale expansion with revenue growth outpacing net income progression, suggesting improving scale efficiency despite quarterly fluctuations.

💰 Margins & Cash Flow

Operating income ranged roughly $0.47–0.56B on revenue run rates of $1.0–$1.34B, implying strong operating margins (~38–50%). The company generated sizeable cash from operating activities in most quarters; cash flow from investing activities was negative but net cash flow remained positive or near break-even, signaling healthy cash generation overall.

🛡️ Balance Sheet & Liquidity

Assets fluctuated around $17–28B across periods; long-term debt typically in the $8–10B range; equity attributable to parent around $3–4B. Leverage exists but liquidity appears adequate; working capital remained positive in most quarters.